drugset / Trial / NCT04717830
An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease
Phase 1
Unknown
25 enrolled
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Open-label safety, tolerability, pharmacokinetics and immunogenicity study in three dose escalation groups
Timeline
- Start
- 2021-02-15
- Primary completion
- 2021-12-31
- Completion
- 2022-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gamezumab | Unknown | — | — |